Trials / Completed
CompletedNCT03375060
Histology Post-Endoscopic Eradication Therapy (EET)
Optimizing Patient Outcomes Through Early Detection of Uncontrolled Acid Reflux After Endoscopic Therapy in Barrett's Esophagus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is looking at a cohort of patients who have undergone treatment for Barrett's Esophagus (BE) and who have experienced complete eradication of the disease. The aim of the proposed study is to evaluate the histologic features of the neosquamous epithelium (NSE) following complete eradication of intestinal metaplasia (CE-IM) in patients undergoing routine surveillance biopsies and compare these data to a direct measure of reflux using 24hr pH impedance, to determine the correlation between histology and persistent reflux. These data will allow us to more accurately risk stratify patients for recurrence of BE following EET.
Conditions
Timeline
- Start date
- 2017-08-02
- Primary completion
- 2017-11-05
- Completion
- 2017-11-05
- First posted
- 2017-12-15
- Last updated
- 2017-12-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03375060. Inclusion in this directory is not an endorsement.